Catalyst Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Catalyst Wealth Management's EW Position: Q1 2023 in Review
Catalyst Wealth Management increased its Edwards Lifesciences (EW) stake by 0.02% in Q1 2023, buying an estimated $79 and bringing the position to 4,336 shares worth $359K. The position accounts for 0.34% of the portfolio, ranked #90.
Catalyst Wealth Management first reported a position in EW in Q4 2022 and has held it in 2 quarters since. 1,247 funds tracked by Wall St. Rank hold EW as of Q1 2023.
- Catalyst Wealth Management held 4,336 shares of Edwards Lifesciences worth $359K as of Q1 2023.
- Catalyst Wealth Management bought 1 Edwards Lifesciences share in Q1 2023, an estimated $79.
- Edwards Lifesciences made up 0.34% of Catalyst Wealth Management's portfolio in Q1 2023, its #90 holding.
- Catalyst Wealth Management first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 2 quarters since.
- 1,247 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2023.
Based on Catalyst Wealth Management's 13F filing for Q1 2023, filed 11 Apr 2023.